IMPLANTS FOR BONE AND CARTILAGE REPAIR
An implant for the repair of bone and cartilage that includes a cell conductive zone that contains biopolymeric fibers and an osteoconductive zone that contains biopolymeric fibers and calcium-containing silicate based glass. The biopolymeric fibers from one zone overlap with the fibers in the other zone forming a stable physical and mechanical integration of the two zones, thus conferring in vivo stability to the implant.
1 . A biocompatible and bioresorbable implant having a physically and mechanically stable bi-phasic structure for the repair of bone and cartilage, comprising a cell conductive zone that contains a first matrix including first biopolymeric fibers and glycosaminoglycans, and an osteoconductive zone that contains a second matrix including second biopolymeric fibers and a calcium-containing silicate based glass, the cell conductive zone is free of calcium-containing silicate based glass, the first biopolymeric fibers extend into the osteoconductive zone and overlap with the second biopolymeric fibers such that the cell conductive zone and the osteoconductive zone are physically and mechanically integrated, the cell conductive zone overlaps with and is in direct contact with the osteoconductive zone.
2 . The implant of claim 1 , wherein the first biopolymeric fibers are formed of a fibrillar collagen.
3 . The implant of claim 2 , wherein the fibrillar collagen is type I collagen, type II collagen, or type III collagen.
4 . The implant of claim 1 , wherein the osteoconductive zone further contains glycosaminoglycans.
5 . The implant of claim 1 , wherein the first matrix has a density of 0.03 g/cm 3 to 0.8 g/cm 3 and a compressive modulus of 0.05 N/cm 2 to 10 N/cm 2 .
6 . The implant of claim 5 , wherein the shape of the implant is a circular cylinder.
7 . The implant of claim 6 , wherein the implant has a length of 0.3 cm to 2 cm and a diameter of 0.2 cm to 3 cm.
8 . The implant of claim 7 , wherein a content of the calcium-containing silicate based glass is from 30% to 95% by weight of the implant.
9 . The implant of claim 8 , wherein a length of the cell conductive zone is 10% to 60% of the length of the implant.
10 . The implant of claim 9 , wherein the implant length is 0.5 cm to 1.25 cm, the diameter is 0.5 cm to 1.5 cm, the content of the calcium-containing silicate based glass is from 60% to 90% by weight of the implant, the length of the cell conductive zone is 15% to 40% of the length of the implant, and the first matrix has a density of 0.05 g/cm 3 to 0.5 g/cm 3 and a compressive modulus of 0.1 N/cm 2 to 5.0 N/cm 2 .
11 . The implant of claim 1 , further comprising a bioactive molecule.
12 . The implant of claim 11 , wherein the bioactive molecule is a growth factor, a cell adhesive molecule, a cytokine, a glycoprotein, a proteoglycan, an antibiotic, or a polysaccharide.
13 . The implant of claim 1 , further comprising cells.
14 . The implant of claim 13 , wherein the cells are osteoblasts, chondrocytes, stem cells, or bone marrow cells.
15 . The implant of claim 1 , wherein the calcium-containing silicate based glass is 45S5 bioglass.
16 . A biocompatible and bioresorbable implant for the repair of bone and cartilage, comprising a matrix that contains biopolymeric fibers and glycosaminoglycans, the matrix having a cell conductive zone and an osteoconductive zone, wherein the osteoconductive zone includes a calcium-containing silicate based glass, the cell conductive zone is free of calcium-containing silicate based glass, the biopolymeric fibers extend from the cell conductive zone into the osteoconductive zone, and the cell conductive zone is in direct contact with the osteoconductive zone.
17 . The implant of claim 16 , wherein the biopolymeric fibers include a fibrillar collagen and the calcium-containing silicate based glass is present at 60% to 90% by weight of the implant.
18 . The implant of claim 17 , wherein the fibrillar collagen is type I collagen and the calcium-containing silicate based glass is 45S5 bioglass.
19 . The implant of claim 18 , wherein the implant is cylindrical, having a length of 0.5 cm to 1.25 cm and a diameter of 0.5 cm to 1.5 cm, and the cell conductive zone has a length equal to 15% to 40% of the implant length.
20 . The implant of claim 19 , wherein the cell conductive zone has a density of 0.05 g/cm 3 to 0.5 g/cm 3 and a compressive modulus of 0.1 N/cm 2 to 5 N/cm 2 .